Amit Shah

Amit is a Principal in our London office and covers venture capital investments in biotech. Prior to joining SR One in early 2018, Amit worked in various roles at GlaxoSmithKline including late phase clinical development, global med affairs, and early pipeline commercial strategy. He is a board certified equivalent plastic surgeon, specialised in microsurgical cancer reconstruction. Since 2020, Amit has sat on the venture capital panel for the BioInnovation Institute, Novo Nordisk’s international life sciences incubator.

Education:

• Amit received his B.A. in Medical Sciences, M.A. in Neuroscience and M.D from the University of Cambridge, UK